3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
8
Gynecologic
7
Head & Neck
5
Breast
4
Lymphoid
1
Gastrointestinal
1
Classical hematology
1
Conditions
Anemia, Refractory, with Excess of Blasts
168
Myelodysplastic Syndromes
160
Leukemia
156
Anemia
151
Leukemia, Myeloid, Acute
144
Neoplasms
124
Precursor Cell Lymphoblastic Leukemia-Lymphoma
115
Leukemia, Myelomonocytic, Chronic
111
Multiple Myeloma
90
Myeloproliferative Disorders
89
Leukemia, Lymphocytic, Chronic, B-Cell
87
Lymphoma, Non-Hodgkin
76
Hodgkin Disease
71
Lymphoma
66
Congenital Abnormalities
64
Anemia, Refractory
64
Venous Thromboembolism
63
Thrombocytopenia
59
Blast Crisis
57
Leukemia, Myeloid, Chronic-Phase
56
Leukemia, Myeloid, Accelerated Phase
52
Lymphoma, Follicular
51
Myelodysplastic-Myeloproliferative Diseases
48
Anemia, Aplastic
46
Primary Myelofibrosis
44
Lymphoma, Mantle-Cell
44
Neoplasms, Plasma Cell
43
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
41
Burkitt Lymphoma
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma in Situ
×
Classical hematology
×
Clear all
NCT02039388
2022-09-02
LUSTIC
Medical University of Vienna
Phase NA
Completed
701 enrolled